| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/05/2022 | Arcutis Biotherapeutics, Inc. | ARQT | Purchase | Common Stock | 250k | $20.00 | $5M | | 08/05/2022 |
| 02/11/2022 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Purchase | Common Stock | 112.7k | $7.10 | $800k | | 02/11/2022 |
| 09/17/2021 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Disposition | Common Stock | 1.2M | $0.00 | $0 | | 09/17/2021 |
| 09/17/2021 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Warrant (Right to Buy) | 1.2M | $0.00 | $1.2k | | 09/17/2021 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Common Stock | 6.4M | $0.00 | $0 | | 02/04/2020 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Common Stock | 2.1M | $0.00 | $0 | | 02/04/2020 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Common Stock | 1.1M | $0.00 | $0 | | 02/04/2020 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Purchase | Common Stock | 500k | $17.00 | $8.5M | | 02/04/2020 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Series A Preferred Stock | 6.4M | $0.00 | $0 | | 02/04/2020 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Series B Preferred Stock | 2.1M | $0.00 | $0 | | 02/04/2020 |
| 02/04/2020 | Arcutis Biotherapeutics, Inc. | ARQT | Conversion | Series C Preferred Stock | 1.1M | $0.00 | $0 | | 02/04/2020 |
| 01/09/2020 | Entasis Therapeutics Holdings Inc. | ETTX | Sale | Common Stock | 50k | $5.00 | $250k | | 01/09/2020 |
| 01/18/2019 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Purchase | Common Stock | 372.4k | $5.37 | $2M | | 01/18/2019 |
| 01/18/2019 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Purchase | Warrant (Right to Buy) | 145.3k | $12.74 | $1.9M | | 01/18/2019 |
| 09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Series B-1 Tranche A Convertible Preferred Stock | 5.2M | $0.00 | $0 | | 09/28/2018 |
| 09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Series B-1 Tranche B Convertible Preferred Stock | 6.7M | $0.00 | $0 | | 09/28/2018 |
| 09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Common Stock | 337.7k | $0.00 | $0 | | 09/28/2018 |
| 09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Common Stock | 251.5k | $0.00 | $0 | | 09/28/2018 |
| 09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Common Stock | 320.9k | $0.00 | $0 | | 09/28/2018 |
| 09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Purchase | Common Stock | 375.9k | $15.00 | $5.6M | | 09/28/2018 |
| 09/28/2018 | Entasis Therapeutics Holdings Inc. | ETTX | Conversion | Series B Convertible Preferred Stock | 7M | $0.00 | $0 | | 09/28/2018 |
| 06/25/2018 | Aptinyx Inc. | APTX | Conversion | Series B Convertible Preferred Stock | 21.9M | $0.00 | $0 | See Footnote | 06/25/2018 |
| 06/25/2018 | Aptinyx Inc. | APTX | Conversion | Common Stock | 795.6k | $0.00 | $0 | | 06/25/2018 |
| 06/25/2018 | Aptinyx Inc. | APTX | Conversion | Common Stock | 1.2M | $0.00 | $0 | | 06/25/2018 |
| 06/25/2018 | Aptinyx Inc. | APTX | Conversion | Common Stock | 1M | $0.00 | $0 | | 06/25/2018 |
| 06/25/2018 | Aptinyx Inc. | APTX | Conversion | Series A-2 Convertible Preferred Stock | 33M | $0.00 | $0 | See Footnote | 06/25/2018 |
| 06/25/2018 | Aptinyx Inc. | APTX | Conversion | Series A-1 Convertible Preferred Stock | 28.9M | $0.00 | $0 | See Footnote | 06/25/2018 |
| 06/25/2018 | Aptinyx Inc. | APTX | Purchase | Common Stock | 150k | $16.00 | $2.4M | | 06/25/2018 |